Literature DB >> 12793519

Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model.

J A Joseph1, N A Denisova, G Arendash, M Gordon, D Diamond, B Shukitt-Hale, D Morgan.   

Abstract

Previously, we showed that blueberry (BB) supplementation reversed the deleterious effects of aging on motor behavior and neuronal signaling in senescent rodents. We now report that BB-fed (from 4 months of age) APP + PS1 transgenic mice showed no deficits in Y-maze performance (at 12 months of age) with no alterations in amyloid beta burden. It appeared that the protective mechanisms are derived from BB-induced enhancement of memory-associated neuronal signaling (e.g. extracellular signal-regulated kinase) and alterations in neutral sphingomyelin-specific phospholipase C activity. Thus, our data indicate for the first time that it may be possible to overcome genetic predispositions to Alzheimer disease through diet.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12793519     DOI: 10.1080/1028415031000111282

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  78 in total

Review 1.  Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Authors:  Magali Dumont; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  The combined effects of exercise and foods in preventing neurological and cognitive disorders.

Authors:  Fernando Gomez-Pinilla
Journal:  Prev Med       Date:  2011-01-31       Impact factor: 4.018

3.  Dietary blueberry supplementation affects growth but not vascularization of neural transplants.

Authors:  Lauren M Willis; Brent J Small; Paula C Bickford; Claudia D Umphlet; Alfred B Moore; Ann-Charlotte E Granholm
Journal:  J Cereb Blood Flow Metab       Date:  2008-02-20       Impact factor: 6.200

4.  Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals.

Authors:  Mark P Mattson; Tae Gen Son; Simonetta Camandola
Journal:  Dose Response       Date:  2007-08-06       Impact factor: 2.658

5.  Blueberry supplementation attenuates microglial activation in hippocampal intraocular grafts to aged hosts.

Authors:  Lauren M Willis; Linnea Freeman; Paula C Bickford; E Matthew Quintero; Claudia D Umphlet; Alfred B Moore; Laura Goetzl; Ann-Charlotte Granholm
Journal:  Glia       Date:  2010-04-15       Impact factor: 7.452

6.  Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.

Authors:  Frédéric Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen H Ashe; Sally A Frautschy; Greg M Cole
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

7.  Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract.

Authors:  Gregory J Brewer; John R Torricelli; Amanda L Lindsey; Elizabeth Z Kunz; A Neuman; Derek R Fisher; James A Joseph
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

8.  Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.

Authors:  Shilpy Dixit; Alexandra Bernardo; Jennifer Michelle Walker; John Andrew Kennard; Grace Youngeun Kim; Eric Sean Kessler; Fiona Edith Harrison
Journal:  ACS Chem Neurosci       Date:  2015-02-12       Impact factor: 4.418

9.  Blueberry-enriched diet protects rat heart from ischemic damage.

Authors:  Ismayil Ahmet; Edward Spangler; Barbara Shukitt-Hale; Magdalena Juhaszova; Steven J Sollott; James A Joseph; Donald K Ingram; Mark Talan
Journal:  PLoS One       Date:  2009-06-18       Impact factor: 3.240

10.  Survival and cardioprotective benefits of long-term blueberry enriched diet in dilated cardiomyopathy following myocardial infarction in rats.

Authors:  Ismayil Ahmet; Edward Spangler; Barbara Shukitt-Hale; James A Joseph; Donald K Ingram; Mark Talan
Journal:  PLoS One       Date:  2009-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.